• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tg Therapeutics (NQ: TGTX )

    27.17 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Tg Therapeutics

    The Most Shorted Stocks in June: Hold, Short, or Squeeze?
    Given the proper catalyst, the short interest in these stocks may lead to a short squeeze. All the market needs is a push and it may come at any time. 
    Via MarketBeat
    Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
    EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Exposures Product Safety
    Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
    From FN Media Group LLC
    Via GlobeNewswire
    TG Therapeutics Stock 300% Rally Has Legs Yet
    There's further upside in the region of 30% yet to be realized, which should be more than enough to get even the more risk averse investor interested. 
    Via MarketBeat
    Exposures COVID-19 Product Safety
    TG Therapeutics, Inc. (NASDAQ:TGTX) Long Term Investor Alert: Investigation of Potential Wrongdoing
    San Diego, CA -- (SBWIRE) -- 11/03/2022 -- Certain directors of TG Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties. 
    Via SBWire
    Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds TG Therapeutics, Inc. (TGTX) Investors of Class Action and Last Few Hours to Actively Participate
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    TG THERAPEUTICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    TGTX FRIDAY DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    NASDAQ:TGTX Investor Alert: Lawsuit Alleges Securities Laws Violations by TG Therapeutics, Inc.
    San Diego, CA -- (SBWIRE) -- 08/17/2022 -- An investor, who purchased shares of TG Therapeutics, Inc. (NASDAQ:TGTX), filed a lawsuit in the over alleged violations of Federal Securities Laws by TG... 
    Via SBWire
    TOP RANKED ROSEN LAW FIRM Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    TGTX Shareholder News: Robbins LLP is Investigating TG Therapeutics, Inc. (TGTX) on Behalf of Shareholders
    From Robbins LLP
    Via Business Wire
    ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - TGTX
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    Bronstein, Gewirtz & Grossman, LLC Notifies TG Therapeutics, Inc. (TGTX) Investors of Class Action and Encourages Investors to Contact the Firm
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    TGTX Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against TG Therapeutics, Inc. (TGTX)
    From Robbins LLP
    Via Business Wire
    Shareholder Alert: Robbins LLP Informs Investors of Class Action Against TG Therapeutics, Inc. (TGTX)
    From Robbins LLP
    Via Business Wire
    TG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    INVESTOR ACTON ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    SHAREHOLDER ACTON NOTICE: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    EQUITY ALERT: Rosen Law Firm Encourages TG Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – TGTX
    From The Rosen Law Firm, P.A.
    Via Business Wire
    TG Therapeutics, Inc. (NASDAQ:TGTX) Investor Alert: Investigation over Potential Wrongdoing
    San Diego, CA -- (SBWIRE) -- 03/23/2022 -- Certain directors of TG Therapeutics, Inc are under investigation over potential breaches of fiduciary duties. 
    Via SBWire
    Global Multiple Sclerosis Drugs Market Expected to Reach $41.99 Billion in 2028
    Palm Beach, FL –– February 3, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system. It is characterized by demyelination,... 
    Via FinancialNewsMedia
    Exposures COVID-19
    TG Therapeutics, Inc. (NASDAQ:TGTX) Investor Notice: Investigation over Possible Violations of Securities Laws
    San Diego, CA -- (SBWIRE) -- 01/20/2022 -- TG Therapeutics, Inc is under investigation over potential securities laws violations in connection with certain financial statements. 
    Via SBWire
    NASDAQ:TGTX Investor Notice: Investigation over Possible Securities Laws Violations by TG Therapeutics, Inc.
    San Diego, CA -- (SBWIRE) -- 01/19/2022 -- An investigation was announced concerning potential securities laws violations by TG Therapeutics, Inc. in connection with certain financial statements. 
    Via SBWire
    TG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TG Therapeutics, Inc. on Behalf of TG Therapeutics Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.